Multaq

Do you see anything wrong with this picture? (Hint: right column) It is certainly true that atrial fibrillation management guidelines needed an update; the last comprehensive update was in 2006.  Much has changed in AF therapy, including the expanded role of catheter ablation and the soon-to-be warfarin substitutes. I guess the European electrophysiologists couldn’t wait [...]

{ Comments on this entry are closed }

I have waited a long time to see even one dronedarone (Multaq) success story.  In the interest of having a fair and balanced blog, I report my first witnessed favorable therapeutic response to the controversial new Sanofi AF drug, dronedarone. Four months ago, I saw him in consultation for an inappropriate ICD shock due to [...]

{ Comments on this entry are closed }

The patient is anxiously sitting on the exam table.  A notebook, a pencil and many papers from the internet and other doctors are close at hand.  A spouse sits in the accompanying chair with an equally anxious face that says without words, “please help us out here.” The problem at hand is atrial fibrillation.  Paroxysms [...]

{ Comments on this entry are closed }